OTC:BLGO | Free Cash Flow | BIOLARGO, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.92M
2025-12-31-$1.59M
2025-03-31-$1.83M
2024-12-31-$1.92M
2024-03-31$481,000.00
2023-12-31-$2,000.00
2023-03-31-$43,000.00
2022-12-31$41,000.00
2022-03-31-$1.14M
2021-12-31-$975,000.00
2021-03-31-$845,000.00
2020-12-31-$836,000.00
2020-03-31-$753,000.00
2019-12-31-$1.24M
2019-03-31-$869,000.00
2018-12-31-$840,000.00
2018-03-31-$996,000.00$18,753.00-$1.01M
2017-12-31-$1.21M
2017-03-31-$1.18M
2016-12-31-$921,816.00
2016-03-31-$986,506.00
2015-12-31-$543,203.00
2015-03-31-$274,506.00
2014-12-31-$302,200.00
2014-03-31-$556,564.00
2013-12-31-$221,045.00
2013-03-31-$465,230.00
2012-12-31-$370,703.00
2012-03-31-$379,000.00
2011-12-31-$381,873.00$0.00-$381,873.00
2011-03-31-$419,350.00
2010-12-31-$584,349.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$8.3M
2024-12-31-$3.21M
2023-12-31-$2.37M
2022-12-31-$2.76M
2021-12-31-$3.94M
2020-12-31-$4.15M
2019-12-31-$4.42M
2018-12-31-$3.89M
2017-12-31-$4.28M$28,671.00-$4.31M
2016-12-31-$3.72M
2015-12-31-$1.88M
2014-12-31-$1.72M
2013-12-31-$1.21M
2012-12-31-$2.03M
2011-12-31-$1.72M$3,740.00-$1.72M
2010-12-31-$1.3M